A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting

Blood Transfusion

Volumn 7, Issue 2, 2009, Pages 127-131

  Ruiz Delgado, Guillermo J ^a,b   Gutiérrez Riveroll, Karla I ^a   Gutiérrez Aguirre, César H ^c   Gómez Almaguer, David ^c   Eyzaguirre Zapata, Renee ^a   Priesca Marin, Manuel ^d   González Carrillo, Martha L ^b   Ruiz Argüelles, Guillermo J ^a,b  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c Hospital Universitario de Nuevo León   (Mexico)

^d Servicios Integrales de Medicina Transfusional Y Hemaféresis de Puebla ^*  (Mexico)

Author keywords

Allografts; Apheresis; Costs saving; Transplantation

Indexed keywords

BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; ITRACONAZOLE; METHOTREXATE; ONDANSETRON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGRAFT; APHERESIS; ARTICLE; BLOOD DONOR; COST BENEFIT ANALYSIS; DRUG DOSE REDUCTION; HUMAN;

ANEMIA, APLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD COMPONENT REMOVAL; BLOOD DONORS; BUSULFAN; CATHETER ABLATION; COST-BENEFIT ANALYSIS; CYCLOPHOSPHAMIDE; FILGRASTIM; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MEXICO; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 66349116504     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2008.0054-08     Document Type: Article

References (16)

1. Ruiz-Argüelles GJ, Gómez-Almaguer D. Making allogeneic bone marrow transplantation available to patients in developing countries: the Mexican experience. Open Hematol J 2008; 2:30-36.
2. Ruiz-Argüelles GJ, Gómez-Almaguer D. Breaking dogmata to help patients: non-myeloablative hematopoietic stem cell transplantation. Expert Opin Biol Ther 2004; 4: 1693-1699 (Pubitemid 39371765)
3. Ruiz-Argüelles GJ, Gómez-Rangel JD, Ponce-de-León S, et al. The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease. Am J Hematol 2004; 75;200-4. (Pubitemid 38451093)
4. Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, González-Llano O, et al. Outpatient allografting using nonmyeloablative conditioning: the Mexican experience. Bone Marrow Transplant 2007; 40:119-123 (Pubitemid 47046209)
5. Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, et al. Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. Bone Marrow Transplant 2005; 36:715-720 (Pubitemid 41518715)
6. Ruiz-Argüelles GJ, Gómez-Almaguer D, Gómez-Rangel JD, et al. Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: a prospective study. Leuk Lymphoma 2004; 45:1191-1195 (Pubitemid 38584902)
7. Gómez-Almaguer D, Vela-Ojeda J, Jaime-Pérez JC, et al. Allografting in patients with severe aplastic anemia using peripheral blood stem cells and a fludarabine-based conditoning regimen: the Mexican experience. Am J Hematol 2006; 81:157-161 (Pubitemid 43297254)
8. Ruiz-Argüelles GJ. The Mexican approach to conduct allogeneic stem cell transplantation: breaking dogmata and facing the Matthew effect. Hematology 2005; 10 (Suppl 1:154-160 (Pubitemid 41825713)
9. Gutiérrez-Aguirre CH, Gómez-Almaguer D, Cantú-Rodríguez OG, et al. Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study. Bone Marrow Transplant 2007: 40:535-539 (Pubitemid 47382123)
10. Ruiz-Argüelles GJ, Tarín-Arzaga LC, González-Carrillo ML, et al. Therapeutic choices in patients with Ph1 (+) chronic myelogenous leukemia living in Mexico in the tyrosine kinase inhibitors (TKI) era: stem cell transplantation or TKI's? Bone Marrow Transplant 2008; 42:23-28
11. Arpaci F, Komurcu S, Ozturk B, et al. A succesful and simplified filgrastim primed single apheresis method without large volume apheresis for peripheral blood stem cell collection. Jap J Clin Oncol 2000; 30: 153-158 (Pubitemid 30335840)
12. Pettengell R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 15:3770-3777 (Pubitemid 24006062)
13. Jones HM, Jones SA, Watts MJ, et al. Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 1994; 12:1693-1702 (Pubitemid 24983466)
14. Alegre A, Díaz MA, Madero L, et al. Large-volume leukapheresis for peripheral blood stem cell collection in children: a simplified single-apheresis approach. Bone Marrow Transplant 1996; 17:923-927 (Pubitemid 26235835)
15. Martino M, Morabito F, Callea I, et al. Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor. Transfus Med 2005;15:323-328 (Pubitemid 41633122)
16. Gajewski JL, Robinson P. Do affluent societies have the only option for the best therapy? Leukemia 2007; 21:387-388